Sarah James
Stock Analyst at Cantor Fitzgerald
(1.98)
# 3,003
Out of 4,905 analysts
280
Total ratings
32.87%
Success rate
-6.08%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNC Centene | Maintains: Overweight | $90 → $65 | $29.14 | +123.06% | 13 | Jul 2, 2025 | |
| HUM Humana | Reiterates: Neutral | $290 | $223.55 | +29.72% | 21 | May 1, 2025 | |
| ELV Elevance Health | Reiterates: Overweight | $485 | $302.45 | +60.36% | 20 | Apr 23, 2025 | |
| CI The Cigna Group | Maintains: Overweight | $350 → $365 | $298.28 | +22.37% | 21 | Mar 20, 2025 | |
| TBRG TruBridge | Maintains: Overweight | $20 → $29 | $21.85 | +32.72% | 6 | Mar 11, 2025 | |
| LFMD LifeMD | Reiterates: Overweight | $15 | $11.10 | +35.14% | 11 | Mar 11, 2025 | |
| THC Tenet Healthcare | Reiterates: Overweight | $177 | $175.14 | +1.06% | 20 | Feb 13, 2025 | |
| HCA HCA Healthcare | Reiterates: Overweight | $405 | $362.60 | +11.69% | 19 | Jan 27, 2025 | |
| UNH UnitedHealth Group | Reiterates: Overweight | $700 | $288.07 | +143.00% | 17 | Jan 17, 2025 | |
| ACHC Acadia Healthcare Company | Reiterates: Neutral | $52 | $22.77 | +128.37% | 13 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $17 | $23.01 | -26.12% | 14 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $219 | $170.82 | +28.21% | 24 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $406 | $204.25 | +98.78% | 11 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $43 | $22.62 | +90.10% | 12 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $16 | $3.76 | +326.10% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $62 | $63.30 | -2.05% | 14 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $1.45 | +244.83% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $8.04 | +24.38% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $97.48 | +3.61% | 7 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $143.38 | -7.24% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $22.55 | +86.25% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $4.23 | +18.20% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $4.02 | +24.38% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $13.15 | +59.70% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $58.84 | -33.72% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $69.50 | +177.70% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.64 | - | 2 | Mar 1, 2017 |
Centene
Jul 2, 2025
Maintains: Overweight
Price Target: $90 → $65
Current: $29.14
Upside: +123.06%
Humana
May 1, 2025
Reiterates: Neutral
Price Target: $290
Current: $223.55
Upside: +29.72%
Elevance Health
Apr 23, 2025
Reiterates: Overweight
Price Target: $485
Current: $302.45
Upside: +60.36%
The Cigna Group
Mar 20, 2025
Maintains: Overweight
Price Target: $350 → $365
Current: $298.28
Upside: +22.37%
TruBridge
Mar 11, 2025
Maintains: Overweight
Price Target: $20 → $29
Current: $21.85
Upside: +32.72%
LifeMD
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $11.10
Upside: +35.14%
Tenet Healthcare
Feb 13, 2025
Reiterates: Overweight
Price Target: $177
Current: $175.14
Upside: +1.06%
HCA Healthcare
Jan 27, 2025
Reiterates: Overweight
Price Target: $405
Current: $362.60
Upside: +11.69%
UnitedHealth Group
Jan 17, 2025
Reiterates: Overweight
Price Target: $700
Current: $288.07
Upside: +143.00%
Acadia Healthcare Company
Dec 10, 2024
Reiterates: Neutral
Price Target: $52
Current: $22.77
Upside: +128.37%
Nov 14, 2024
Maintains: Overweight
Price Target: $30 → $17
Current: $23.01
Upside: -26.12%
Oct 25, 2024
Reiterates: Neutral
Price Target: $219
Current: $170.82
Upside: +28.21%
Oct 24, 2024
Reiterates: Overweight
Price Target: $406
Current: $204.25
Upside: +98.78%
Oct 4, 2024
Reiterates: Overweight
Price Target: $43
Current: $22.62
Upside: +90.10%
Oct 4, 2024
Reiterates: Overweight
Price Target: $16
Current: $3.76
Upside: +326.10%
Oct 1, 2024
Reiterates: Neutral
Price Target: $62
Current: $63.30
Upside: -2.05%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $1.45
Upside: +244.83%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $8.04
Upside: +24.38%
Jul 25, 2024
Reiterates: Neutral
Price Target: $101
Current: $97.48
Upside: +3.61%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $143.38
Upside: -7.24%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $22.55
Upside: +86.25%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $4.23
Upside: +18.20%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $4.02
Upside: +24.38%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $13.15
Upside: +59.70%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $58.84
Upside: -33.72%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $69.50
Upside: +177.70%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.64
Upside: -